Tirupati Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 3.79 M
as on 08-07-2024
- Company Age 24 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 19.40 Cr
as on 08-07-2024
- Satisfied Charges ₹ 46.90 Cr
as on 08-07-2024
- Revenue -26.17%
(FY 2022)
- Profit -42.09%
(FY 2022)
- Ebitda 51.83%
(FY 2022)
- Net Worth 8.86%
(FY 2022)
- Total Assets -0.06%
(FY 2022)
About Tirupati Bio-Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 3.79 M.
The company currently has active open charges totaling ₹19.40 Cr. The company has closed loans amounting to ₹46.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Divya Goyal, Amay Garg, and Ankit Garg serve as directors at the Company.
- CIN/LLPIN
U74899DL2000PLC107500
- Company No.
107500
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2000
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tirupati Bio-Tech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya Goyal  | Director | 10-Jun-2021 | Current |
| Amay Garg | Additional Director | 10-Jul-2023 | Current |
| Ankit Garg | Additional Director | 11-Jul-2023 | Current |
Financial Performance and Corporate Structure Insights of Tirupati Bio-Tech.
Tirupati Bio-Tech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.17% decrease. The company also saw a substantial fall in profitability, with a 42.09% decrease in profit. The company's net worth moved up by a moderate rise of 8.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tirupati Bio-Tech?
In 2022, Tirupati Bio-Tech had a promoter holding of 23.90% and a public holding of 76.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Aug 2023 | ₹4.00 M | Open |
Adarsh Mahila Mercantile Co-Operative Bank Ltd. Creation Date: 07 May 2015 | ₹1.00 Cr | Open |
Indian Overseas Bank Creation Date: 06 Jan 2012 | ₹3.00 Cr | Open |
How Many Employees Work at Tirupati Bio-Tech?
Unlock and access historical data on people associated with Tirupati Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tirupati Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tirupati Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
